Literature DB >> 12872265

BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy.

L Stuppia1, P Di Fulvio, G Aceto, S Pintor, S Veschi, V Gatta, A Colosimo, E Cianchetti, A Cama, R Mariani-Costantini, P Battista, G Palka.   

Abstract

We report on the screening of the entire BRCA1/BRCA2 coding sequence by SSCP, PTT, and direct sequencing in 68 Italian families with recurrent breast or ovarian cancer. For each investigated proband, the probability of being carrier of a BRCA1/BRCA2 mutation was evaluated using the BRCAPRO software. We detected BRCA1/BRCA2 mutations in 8 patients (11.7%). However, if considering only patients with a carrier probability >10%, the detection rate was 36.8%, confirming the usefulness of the BRCAPRO software. One change (BRCA1 4172insT) was a novel mutation not reported in BIC database. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12872265     DOI: 10.1002/humu.9164

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

Review 1.  Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.

Authors:  Furu Wang; Qiaoqiao Fang; Zhen Ge; Ningle Yu; Sanxiao Xu; Xiangyong Fan
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

2.  Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.

Authors:  Ivana Antonucci; Martina Provenzano; Luca Sorino; Michela Balsamo; Gitana Maria Aceto; Pasquale Battista; David Euhus; Ettore Cianchetti; Patrizia Ballerini; Clara Natoli; Giandomenico Palka; Liborio Stuppia
Journal:  J Hum Genet       Date:  2016-12-08       Impact factor: 3.172

Review 3.  Psychological aspects, risk and protective factors related to BRCA genetic testing: a review of the literature.

Authors:  Lucia Lombardi; Sonia M Bramanti; Alessandra Babore; Liborio Stuppia; Carmen Trumello; Ivana Antonucci; Alessandra Cavallo
Journal:  Support Care Cancer       Date:  2019-06-15       Impact factor: 3.603

4.  Performance of BRCA1/2 mutation prediction models in Asian Americans.

Authors:  Allison W Kurian; Gail D Gong; Nicolette M Chun; Meredith A Mills; Ashley D Staton; Kerry E Kingham; Beth B Crawford; Robin Lee; Salina Chan; Susan S Donlon; Yolanda Ridge; Karen Panabaker; Dee W West; Alice S Whittemore; James M Ford
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

5.  Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry.

Authors:  Allison W Kurian; Gail D Gong; Esther M John; Alexander Miron; Anna Felberg; Amanda I Phipps; Dee W West; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

6.  The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.

Authors:  Vida Stegel; Mateja Krajc; Janez Zgajnar; Erik Teugels; Jacques De Grève; Marko Hočevar; Srdjan Novaković
Journal:  BMC Med Genet       Date:  2011-01-14       Impact factor: 2.103

7.  Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.

Authors:  Sunita Saxena; Anurupa Chakraborty; Mishi Kaushal; Sanjeev Kotwal; Dinesh Bhatanager; Ravindar S Mohil; Chintamani Chintamani; Anil K Aggarwal; Veena K Sharma; Prakash C Sharma; Gilbert Lenoir; David E Goldgar; Csilla I Szabo
Journal:  BMC Med Genet       Date:  2006-10-04       Impact factor: 2.103

8.  Relationship between MUTYH, OGG1 and BRCA1 mutations and mRNA expression in breast and ovarian cancer predisposition.

Authors:  Carmelo Moscatello; Marta Di Nicola; Serena Veschi; Patrizia Di Gregorio; Ettore Cianchetti; Liborio Stuppia; Pasquale Battista; Alessandro Cama; Maria Cristina Curia; Gitana Maria Aceto
Journal:  Mol Clin Oncol       Date:  2020-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.